Publication | Closed Access

Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study

Xpg MutationsMedicineTreatment ResponseGynecologyCancer TreatmentCancer GeneticsOncologyRadiation OncologyPhase 3Ovarian Cancer